
Rabikon 20mg Tablet
Marketer
Sanko Biotech
Salt Composition
Rabeprazole (20mg)
Overview Rabikon 20mg Tablet
Gastro-acid reducer Acidaze 20mg tablets diminish stomach acid production. Indicated for managing acid-related gastrointestinal disorders like reflux, peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and aids healing. Acidaze 20mg should be ingested an hour pre-meal, ideally mornings. Dosage is condition- and response-dependent; consistent daily timing, as directed by your physician, is crucial, even with rapid symptom resolution. Dietary modifications, including smaller, more frequent meals, and avoidance of caffeine, spicy foods, and fats, may enhance symptom control. Common, generally mild, side effects encompass nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Persistent or bothersome effects necessitate medical consultation. Prolonged use (exceeding one year), particularly at higher doses, elevates bone fracture risk. Discuss bone loss prevention strategies, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) can occur after three months of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Magnesium level monitoring may be necessary. Acidaze 20mg is unsuitable for individuals with severe hepatic impairment, those on HIV medication, those with prior allergies to similar drugs, or pre-existing osteoporosis. Pregnant or lactating women should seek medical advice before use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Rabikon 20mg Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Rabikon 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Rabikon tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rabikon 20mg Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Rabikon 20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the 20mg Rabikon tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Rabikon 20mg Tablet works:
Gastric acid production is diminished by the proton pump inhibitor Rabikon 20mg tablets, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabikon 20mg Tablet concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Rabikon 20mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Rabikon 20mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Rabikon 20mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Rabikon 20mg Tablets pose no safety concerns. No alteration to the Rabikon 20mg Tablet dosage is necessary.
LiverSAFE IF PRESCRIBED
Patients with liver impairment may safely use Rabikon 20mg tablets without requiring a dosage modification.
What if you forget to take Rabikon 20mg Tablet :
Should you forget a Rabikon 20mg Tablet dose, take it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabikon 20mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
